Madison, CT, United States of America

Chuanbo Xu

This inventor holds 1 USPTO granted patent. Top assignee: Genaissance Pharmaceuticals, Inc.. Active years: 2006.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 131(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Genetics: Chuanbo Xu

Introduction: Chuanbo Xu, based in Madison, Connecticut, is an accomplished inventor known for his significant contributions to the field of genetics. With a keen focus on haplotype data analysis, his work has the potential to greatly influence personalized medicine and genetic research.

Latest Patents: Chuanbo Xu holds a patent titled "Methods for obtaining and using haplotype data." This innovative patent encompasses methods, computer programs, and databases designed to analyze and utilize gene haplotype information effectively. His invention includes strategies for measuring haplotype frequencies in the general population, assessing correlations between individual haplotypes or genotypes and clinical outcomes, and predicting individual clinical responses to treatments based on genetic makeup.

Career Highlights: Chuanbo Xu is a pivotal member of Genaissance Pharmaceuticals, Inc., where he actively contributes to advancing genetic research. His work not only reflects his expertise but also his commitment to improving healthcare through actionable insights gained from genetic data.

Collaborations: Working alongside esteemed colleagues such as R Rex Denton and Richard S Judson, Chuanbo Xu fosters a collaborative environment that encourages innovation and shared knowledge in the field of genetics.

Conclusion: Chuanbo Xu's contributions to the understanding and application of haplotype data underscore the importance of innovation in genetics. His work serves as an inspiration for future advancements in personalized medicine and the use of genetic information to improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…